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Abstract
Invasive pneumococcal disease causes substantial morbidity and mortality in Africa. Evalu-
ating population level indirect impact on adult disease of pneumococcal conjugate vaccine
(PCV) programmes in infants requires baseline population incidence rates but these are
often lacking in areas with limited disease surveillance. We used hospital based blood cul-
ture and cerebrospinal fluid surveillance to calculate minimal incidence of invasive pneumo-
coccal disease in the adult (15 years old) population of Blantyre, a rapidly growing urban
centre in southern Malawi, in the period preceding vaccine introduction. Invasive pneumo-
coccal disease incidence in Blantyre district was high, mean 58.1 (95% confidence interval
(CI): 53.7, 62.7) per 100,000 person years and peaking among 35 to 40 year olds at 108.8
(95%CI: 89.0, 131.7) mirroring the population age prevalence of HIV infection. For pneumo-
coccal bacteraemia in urban Blantyre, mean incidence was 60.6 (95% CI: 55.2, 66.5) per
100,000 person years, peaking among 35 to 40 year olds at 114.8 (95%CI: 90.3, 143.9).
We suspected that our surveillance may under-ascertain the true burden of disease, so we
used location data from bacteraemic subjects and projected population estimates to calcu-
late local sub-district incidence, then examined the impact of community level socio-demo-
graphic covariates as possible predictors of local sub-district incidence of pneumococcal
and non-pneumococcal pathogenic bacteraemia. Geographic heterogeneity in incidence
was marked with localised hotspots but ward level covariates apart from prison were not as-
sociated with pneumococcal bacteraemia incidence. Modelling suggests that the current
sentinel surveillance system under-ascertains the true burden of disease. We outline a
number of challenges to surveillance for pneumococcal disease in our low-resource setting.
Subsequent surveillance in the vaccine era will have to account for geographic heterogene-
ity when evaluating population level indirect impact of PCV13 introduction to the childhood
immunisation program.
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Introduction
Streptococcus pneumoniae is an important pathogen particularly in children and HIV infected
adults in sub-Saharan Africa[1–3]. Pneumococcal conjugate vaccination of children has re-
sulted in reduced invasive pneumococcal disease (IPD) incidence in unvaccinated adults in in-
dustrialised countries and in HIV-infected adults in middle income countries [2,4–6]. A
similar effect from paediatric vaccination in low income countries in Africa with generalised
HIV epidemics would be of major benefit and obviate the need to vaccinate high risk adults in
whom direct vaccination is of proven benefit[1]. However, in communities with a high burden
of pneumococcal disease, diverse pneumococcal serotype distribution in invasion and carriage
and high prevalence of HIV infection it is plausible that older unvaccinated children or adults
may themselves be a source for ongoing community transmission of pneumococcus. It is there-
fore important to determine whether such indirect effects will occur with conjugate vaccine in-
troduction and if they do whether their magnitude obviate the benefit of direct vaccination of
adults. One method of determining vaccine impact is to compare pre vaccine introduction dis-
ease rates with those after introduction. Whilst conceptually simple, this method has several
potential sources of error, but as minimum requirements, baseline calculation of rates of dis-
ease and consistent methods used for disease surveillance and ascertainment over time are
essential.
Incidence rates for IPD are difficult to obtain in many resource poor settings because of lack
of laboratory capacity or lack of epidemiological surveillance infrastructure[7]. Even where lab-
oratory capacity is available in a sentinel site, the accurate determination of disease incidence
can be challenging. Case ascertainment is hampered by prior use of antibiotics on empirical
grounds which reduces the yield of a blood culture surveillance system, and this practice is
common in a setting where syndromic management is encouraged[8]. Blood culturing tech-
nique may also be sub-optimal, in particular the volume of cultured blood is a key determinant
of blood culture sensitivity to detect pneumococcal blood stream infection[9]. Additionally, de-
termining the true denominator of the population can be challenging in a complex urban set-
ting where hospitals serve both referral level and primary healthcare functions to the urban
and peri-urban population, particularly when primary health facility service provision may be
patchy. As a consequence very little is known about population incidence of pneumococcal dis-
ease in Africa. Few paediatric incidence estimates have been published[2,10–12], in HIV in-
fected adult cohorts rates of over 200 per 100,000 are reported from South Africa[3] and higher
still in Kenya[13], but general population incidence is lacking for low-income countries in sub-
Saharan Africa. We sought to fill this gap by estimating a minimum incidence for IPD in our
setting and by using available datasets to examine to what extent we may be under-ascertaining
the true burden of disease.
Previous work in Blantyre Malawi had confirmed the important role of IPD as a cause of
morbidity and mortality in the adult population, particularly those HIV-infected[14]. We had
also shown the need to standardise blood culture surveillance in order to maximise IPD diag-
nosis[9]. As a component of this work, we conducted enhanced surveillance for pneumococcal
bacteraemia in 2005–2006 at the adult Accident & Emergency Department of Queen Elizabeth
Central Hospital (QECH) in Blantyre, Malawi. QECH is the major referral centre for the south-
ern region of Malawi, and services the population of Blantyre district which numbered just
over 1 million persons at the 2008 census[15]. QECH provides referral and primary level care
to the population in Blantyre city and its peri-urban rural areas and is the only referral level fa-
cility providing free healthcare in the district [16,17]. Most severe illness episodes in persons at-
tending for care at local clinics are referred to QECH. Although it is unknown how many
severe illness episodes do not attend for care and may die at home, those who do attend care do
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so at QECH. Blantyre city comprises urbanised and semi-urbanised farming areas, and is simi-
lar to urban and peri-urban settings in much of sub-Saharan Africa. We report the baseline in-
cidence rate of IPD among adults in the era preceding introduction of pneumococcal conjugate
vaccination to the child population in Malawi, and estimate the degree of possible under-ascer-
tainment of our surveillance system by examining the apparent heterogentiy in incidence.
Materials and Methods
Case ascertainment
All persons 15 years or older presenting to the Accident & Emergency Department of QECH
with a febrile (>37.5°C) illness, clinical pneumonia or who were otherwise seriously ill to in-
clude sepsis in the differential diagnosis, on any day of the week during the period 1 January
2005 to 31 December 2006 had blood culture performed by a specialised team of phlebotomists
in accordance with standard operating procedures[9] (Table 1). Blood was transported to the
laboratory and processed as previously described[9]. Blood culture contaminants were defined
using standard guidelines[18]. Persons presenting with suspected meningitis had lumbar punc-
ture performed as part of routine care. We used our laboratory database to obtain the identifiers
of all persons with pneumococcus isolated in cerebrospinal fluid. Pleural taps are not performed
at our institution. In order to avoid double counting when cultures of blood and cerebrospinal
fluid were both positive during the same illness episode we matched this list to our bacteraemic
cohort on basis of identity of all 4 of given name, family name, age in years and specimen date.
We accounted for linguistic characteristics of the Chichewa language (e.g. interchange of letters
R and L, or the addition of letter i at the end of a word) and accepted homophonic spellings as
identical (e.g. Irene and Ireen). We allowed +/-5 days between blood culture and cerebrospinal
fluid specimen collection dates. The laboratory cerebrospinal fluid dataset included persons
from Blantyre district but did not specify their location of residence within the district.
Denominators and socio-demographic indicators
Population denominators for each sub-district ward for the observation period 2005 to 2006
were derived from population growth occurring during the inter-censal period of 1998 to 2008
Table 1. Prevalence of Covariates Among Adults With andWithout Pneumococcal Bacteraemia, Queen Elizabeth Central Hospital, Blantyre Ma-
lawi, 1 January 2005 to 31 December 2006.
Covariate Entire cohort Non-pneumococcal bacteraemia Pneumococcal bacteraemia Culture negative P-value *
N = 8,891 N = 1622 N = 559 N = 6710
Female 5,065 (57.0%) 925 (57.0%) 322 (57.6%) 3818 (56.9%) 0.75
Mean age in yrs (SD) 34.3 (11.6) 34.7 (11.4) 34.3 (10.5) 34.2 (11.7) 0.86
ART 738 (8.4%) 136 (8.4%) 41 (7.3%) 561 (8.4%) 0.40
TB therapy 409 (4.6%) 88 (5.4%) 29 (5.2%) 292 (4.4%) 0.36
Antifungal therapy 65 (0.7%) 16 (1.0%) 0 49 (0.7%) 0.19
Fever >37.5 oC † 5,884 (66.2%) 1115 (68.7%) 456 (81.6%) 4313 (64.3%) <0.01
Prior antibiotics 1,907 (21.5%) 296 (18.3%) 85 (15.2%) 1526 (22.7%) <0.01
Prisoner 80 (0.9%) 9 (0.6%) 12 (2.2%) 59 (0.8%) <0.01
Died 109 (1.2%) 28 (1.7%) 40 (7.2%) 41 (0.6%) <0.01
SD = standard deviation; ART = antiretroviral therapy; TB = tuberculosis
*Comparing pneumococcal bacteraemic cohort with culture negative cohort. All by X2-test, except antifungal therapy by Fisher's exact test with rounding
up of cells.
† at presentation
doi:10.1371/journal.pone.0128738.t001
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by assuming the difference between the population at the two censuses is linearly distributed
and deriving the mean of the projected mid-year estimates for 2005 and 2006. Since this esti-
mate is linear it likely overestimates the population at any time point, thus underestimating in-
cidence rates, though given the proximity to the 2008 census the degree of error is likely to be
small. Socio-demographic ward level indicators from the 2008 census were used[15]. Kilometre
walking distance by mapped road (excludes unsealed local tracks) was measured from the cen-
tre of each ward to QECH.
Statistical Analysis
Recalling the challenges of obtaining true population incidence of IPD, minimum estimates of
hospitalised IPD incidence with exact Poisson confidence intervals were derived by dividing
the number of observed IPD (pneumococcal bacteraemia plus meningitis) cases by person
years of observation for the population denominators stratified by age and multiplied by
100,000. For bacteraemic cases we had data on home location so also stratified ward-specific
denominators and multiplied by 100,000. We were unable to obtain data on primary health
care utilisation which may have helped us understand variability in health seeking behaviour.
So we explored associations between ward level socio-demographic covariates (Table 2) and in-
cidence of hospitalised pneumococcal bacteraemia (but not meningitis) events using multivari-
able negative binomial regression believing these would provide an acceptable proxy. We
allowed repeat events within individuals and used Huber-White robust estimators to account
for the consequent correlation between outcome events[19]. Our aim thereby was to estimate
to what degree our surveillance system may under-ascertain the true burden of disease. Nested
models were compared and parameter associated P-values were derived from the likelihood
Table 2. Ward Level Predictors of Pneumococcal Bacteraemia Incidence.
Covariate* IRR (95% CI) P-value
Number of households included in census from that ward 1.00 (1.0, 1.0) 0.68
Proportion of dwellings that are permanent 2.96 (0.6, 15.2) 0.19
Proportion of dwellings that are owner occupied 0.47 (0.06, 3.6) 0.47
Proportion of dwellings that have non-grass rooﬁng a 3.01 (0.4, 20.7) 0.26
Proportion of dwellings that have burnt brick or concrete walls 2.19 (0.4,11.3) 0.35
Proportion of dwellings that have sealed ﬂoor b 2.81 (0.45, 17.3) 0.27
Crowding index c 0.14 (0.01, 1.3) 0.08
Proportion of dwellings whose main water source is unprotected d 0.17 (0.0, 11.7) 0.42
Proportion of dwellings that have a ﬂush toilet 1.72 (0.5, 6.1) 0.40
Proportion of dwellings that use electricity for lighting 2.41 (0.5, 11.8) 0.28
Proportion of dwellings that own a radio 8.80 (0.0, 2449.2) 0.45
Proportion of dwellings that own an insecticide treated net 0.52 (0.02, 15.2) 0.71
Proportion of adult persons not literate in any language 0.11 (0.0, 13.6) 0.37
Presence of prison in the ward 4.38 (2.6, 7.3) <0.001
Walking distance from QECH† 0.63 (0.3, 1.3) 0.22
* All but last covariate are from 2008 Census of Population and Housing [15]
† Shortest walking distance by mapped road from centre of ward to QECH
a Non-grass rooﬁng: tin/iron, tiles, asbestos, cement
b Sealed ﬂoor: parquet, polished wood, vinyl, asphalt, ceramic tiles, cement, bricks
c Crowding index: mean number or occupants divided by mean number of sleeping rooms
d Unprotected water source: spring, river/stream, pond/lake, dam, rain water, unprotected well
doi:10.1371/journal.pone.0128738.t002
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ratio test, forward stepwise regression was also performed by including covariates achieving
P<0.2 on univariable analysis. We did not examine variance inflation factors for our socio-de-
mographic covariates as we were not aiming to examine the relative contribution of each factor
per se, but rather aimed to adjust total ward level incidence for differences in socio-demo-
graphic covariates thereby allowing for prediction of expected number of cases by ward. We
then compared these predicted expectations against the empirically observed case numbers. In
so doing we were attempting to answer the following: if un-ascertained cases are indeed occur-
ring at a rate predicted by our models, how does this modelled rate compare with the actual
rate we have empirically observed? We separately modelled for associations with pneumococ-
cal and non-pneumococcal bacteraemia. As a sensitivity analysis we reran the analysis exclud-
ing incarcerated persons. This observational study was a post-hoc analysis conducted on a
cohort of patients recruited as a consequence of hospital surveillance for bloodstream infection,
so we did not undertake sample size calculations for our cohort. Analyses were performed
using Stata 12.1 (Statacorp, College Station, Texas).
Ethics
All adults and adolescents presenting to the adult Accident & Emergency Department at
QECH and fulfilling clinical indications had a blood culture collected through enhancement of
routine clinical care provision. Persons aged 15 to 17 years attending hospital independently
and cared for in adult wards are generally considered capable of providing their own consent
for medical care under ethical norms in Malawi. Their location of residence was accessed retro-
spectively by interrogation of institutional database following ethical approval. For persons ful-
filling enrolment criteria for a related clinical trial [1] additional data were collected after
informed written consent was obtained from them if 18 years or older or from an attending
parent or guardian if aged 15 to 17 years. We did not exclude populations at high risk for pneu-
mococcal disease, including those on antiretroviral therapy or those residing in correctional in-
stitutions. This work was approved by the University of Malawi, College of Medicine Research
Ethics Committee (approval numbers P.99/00/101 and P.01/08/609).
Results
Descriptive statistics
During 727 days of continuous surveillance, we recruited a cohort of 8,891 adults and adoles-
cents aged 15 years or older who presented to QECH and fulfilled inclusion criteria. Among
these participants we isolated a significant pathogen in 1724 (19.4%) including S. pneumoniae
in 559 cases (6.3% of study cohort and 32.4% of pathogens), non-typhoidal Salmonella in 626
(7.0% and 36.3% of cohort and of pathogens respectively), E. coli in 177 (2.0% and 10.3% re-
spectively), C. neoformans in 162 (1.8% and 9.4% respectively). Mean age of participants with
pneumococcal bacteraemia and among those with negative culture was 34.3 (95% confidence
interval (CI): 33.4, 35.1) and 34.2 (95%CI: 33.9, 34.4) years respectively, P = 0.86. Among the
recruited bacteraemic cohort there were 46 cases that had S. pneumoniae isolated from cerebro-
spinal fluid. In addition a further 91 persons also had pneumococcal meningitis during the
same period. Mean age was 31.9 (95%CI: 29.6, 34.3) years and 54 (60%) were female. Among
bacteraemic patients the predominance of females in the cohort was associated with antiretro-
viral therapy (ART). Among persons on ART 61.8% were female, among those not on ART
56.5% were female (P<0.01).
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Incidence
Our surveillance spanned 1,119,158 person years of observation. Among adults 15 years and
older resident in Blantyre district (city plus rural area) IPD incidence was 58.1 (95% CI: 89.0,
131.7) per 100,000 person years and peaking among 35 to 40 year olds at 108.8 (95%CI: 89.0,
131.7). For pneumococcal bacteraemia (not including non-bacteraemic meningitis) incidence
was 50.0 (95%CI: 45.9, 54.3), and the peak at 35 to 40 year olds was 97.4 (95%CI: 78.7, 119.2).
Because place of residence was known for bacteraemic cases we were able to calculate incidence
within Blantyre city. In urban Blantyre incidence of pneumococcal bacteraemia was 60.6 (95%
CI: 55.2, 66.5) and was greatest among 35 to 40 year olds at 114.8 (95%CI: 90.3, 143.9) (Fig 1).
Incidence of bacteraemia varied among Blantyre wards and from many wards no cases were
observed during the period of surveillance (Fig 2). Among wards where cases were observed,
the mean incidence was 95.6 per 100,000 and the pattern of high incidence in mid-adulthood
decades was consistent. For certain age groups in specific locations the incidence was very high
(Fig 2). For example, Chichiri ward houses a large prison, 77 of the 80 (96.3%) prisoners in the
cohort resided in Chichiri. Of 14 cases of pneumococcal bacteraemia from Chichiri ward, 12
(85.7%) were among prisoners. Including and excluding prisoners from case counts but assum-
ing the same denominator, incidence in Chichiri was 187.1 (95%CI: 161.2, 215.8) per 100,000
and 26.7 (95%CI: 17.8, 39.3) per 100,000 respectively.
Estimating under-ascertainment
Given the heterogeneity in ward level incidence, we calculated expected incidence by ward
after adjusting for ward level covariates. Among all socio-demographic covariates, only the
presence of a prison in the ward was associated with pneumococcal bacteraemia incidence
Fig 1. Population Incidence of Invasive Pneumococcal Disease in Blantyre, Malawi, among Adults
15 years, 1 January 2005 to 31 December 2006. Includes isolated pneumococcal bacteraemia, isolated
pneumococcal meningitis and bacteraemic meningitis in Blantyre District (City and Rural).
doi:10.1371/journal.pone.0128738.g001
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Fig 2. Map of Population Incidence of Pneumococcal Bacteraemia by Sub-district Ward among Adults15 years, 1 January 2005 to 31 December 2006.
doi:10.1371/journal.pone.0128738.g002
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(Incidence Rate Ratio 4.38, 95%CI: 2.63, 7.31, P<0.001) (Table 2), and none was associated
with non-pneumococcal bacteraemia. There were no significant differences in any socio-demo-
graphic covariates between wards where cases were or were not detected (data not shown). Ad-
justing for socio-demographic covariates, the average predicted number of cases per ward was
43.7 and the mean incidence was 105.2 per 100,000. The expected total number of events ad-
justing for ward size was 1153 events, compared with 559 events actually observed, implying
our sentinel site detected only 48.5% of the true disease burden. The socio-demographic adjust-
ed model predictions had cases occurring in all wards, a phenomenon which we did not ob-
serve empirically (data not shown).
Discussion
Malawi is largely rural but is undergoing rapid urbanisation[20,21]. Our study was located in a
large urban and peri-urban setting typical of many population centres on the continent that
have high HIV prevalence, poverty and dense urban living. In our setting pneumococcus is a
leading cause of bloodstream infection and meningitis and is associated with substantial mor-
tality. We set out to estimate the population incidence of invasive pneumococcal disease
among adults living in Blantyre prior to the introduction of PCV13 into the infant vaccine
schedule. We used data collected at the major hospital providing care to the residents of Blan-
tyre, and used methods that have been carried forward into the infant vaccine era.
The minimum incidence rate for pneumococcal bacteraemia identified was 60.6 per 100,000
person years and close to double that in the age group with highest HIV prevalence. In some
wards incidence was much higher and approached published rates for HIV infected adults[22].
Adults in Blantyre had a high incidence of pneumococcal bacteraemia compared with adult
populations in other locations prior to conjugate vaccine introduction[23–26]. The profile of
the incidence curve by age differs to that observed in low HIV prevalence settings, with peak in-
cidence occurring in the middle decades of adulthood rather than in old age. The peak inci-
dence for pneumococcal bacteraemia coincides with peak prevalence of HIV infection from
large scale cross-sectional surveys in the same setting[20]. The association between HIV and
high incidence of pneumococcal disease has been demonstrated clearly[26–28]. Comparison of
incidence rates across populations with vastly differing HIV prevalence may be misleading.
Age-distribution also differs for urban and rural location. Anecdotally many older persons re-
turn to their rural home villages upon leaving the workforce in the city.
We found heterogeneity in incidence within Blantyre district. Adjusting for socio-demo-
graphic covariates and for prison, the predicted incidence and expected number of events were
much higher than was observed. Our modelling also predicted that cases should occur in all
wards. The implication is that heterogeneity in incidence is at least in part due to under-ascer-
tainment. However, it is likely that unmeasured covariates also accounted for the heterogeneity
since the ward level socio-demographic covariates we were able to obtain were not indepen-
dently associated with bacteraemia incidence and wards with no apparent cases did not differ
socio-demographically from wards where cases were observed. Data on care seeking, on the
functioning of health centres or performance indicators or referral patterns were not available,
though these factors could also plausibly contribute to heterogeneity in incidence. Among the
locations with high incidence one (Chichiri) was the site of a large prison while the other
(Limbe West) housed a large police barracks. Closed communities are known to be at risk of
pneumococcal disease outbreaks and in these instances one might also conjecture an associa-
tion with HIV prevalence. Although in our cohort, being in prison was not associated with
ART or TB therapy. Additionally, localised serotype specific outbreaks could plausibly occur in
other local communal settings also contributing to the observed heterogeneity.
Adult IPD Incidence in Malawi
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Limitations
Our observed incidence rate is likely a minimal estimate. We did not use antigen detection or
polymerase chain reaction, even in those previously receiving antibiotics, nor did we collect
pleural fluid, all of which may have increased our yield. We focussed on invasive disease so
have not accounted for the total burden of pneumococcal disease, such as non-bacteraemic
pneumonia. We excluded from our numerator persons not usually resident in Blantyre district.
The weak referral systems and suboptimal supply of drugs and services within Blantyre means
we will have missed persons dying at home of pneumococcal disease. Despite this, our sentinel
site represents the only publicly funded facility providing free care to the district. Although two
private facilities exist, the associated costs make care prohibitively expensive for all but the very
wealthiest. These facilities do not have bacterial culture capacity. The accuracy of our inter-cen-
sal population denominator estimates is unknown. We back-cast the population estimates in
the study period using the method described above. Given the proximity of the study period to
the subsequent census, we believe any error is likely to be small and will only make the inci-
dence estimate conservative, we acknowledge that our method becomes less useful for longer
term projections. Although our data do not immediately precede vaccine introduction, they do
represent a period of stable clinical surveillance among adults in Blantyre and thereby provide
a valid estimate of incidence during the study period. Despite Blantyre being typical of many
rapidly urbanising population centres in sub-Saharan Africa, care should be taken in generalis-
ing our findings to rural areas of Malawi and indeed to other countries in the region. Our data
contribute to the body of data from adult surveillance populations in Africa but should be
taken in context of work from other sites such as the Gambia and South Africa, although adult
data from the continent are still sparse [29,30]. It is likely however, that the challenges we faced
in producing robust baseline estimates that would be useful for post-vaccine introduction com-
parisons would be similar in other poorly-resourced settings.
Our inability to find an association between ward level socio-demographic covariates and
incidence may have to do with the arbitrary demarcation of wards. Economically disparate but
adjacent populations that are counted within a single ward will mask any underlying socioeco-
nomic differences. The socio-demographic indicators we used were collected in 2008. We did
not attempt to infer the socio-demographic status for our study period 2005–6 so may have
been misled by any rapid changes in living standards had these occurred. Additionally we
lacked data on ward level HIV prevalence which may also contribute to heterogeneity in pneu-
mococcal disease. The lack of health service performance data and referral patterns are impor-
tant limitations, since these factors may account for heterogeneity in observed incidence at our
referral centre. Since our model based predictions of expected incidence did not include these
data, that estimate should be interpreted with caution. Despite these limitations we believe our
argument stands—it is likely that our surveillance system, and so too those is similarly resource
poor settings likely underestimates the true burden of disease. We plan to undertake an evalua-
tion of primary health centre provision and performance, together with locally specific vaccine
coverage rates among infants and HIV prevalence in households to inform future incidence
evaluations and thereby integrate our surveillance systems with the district health office to fur-
ther strengthen the health system of Blantyre. Additionally in order to infer indirect vaccine
impact it is crucial to evaluate the dynamics of pneumococcal serotype distribution at popula-
tion level before and after vaccine introduction, a process that is currently underway.
Implications for vaccine impact assessment. In much of Africa evaluation of vaccine im-
pact will rely on before-after sentinel surveillance. Our finding of geographically heterogeneous
ascertainment through differential care seeking or survivorship bias has important implications
for the design and conduct of post vaccine introduction surveillance in a complex urban and
Adult IPD Incidence in Malawi
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peri-urban setting such as Blantyre. Active surveillance systems that reduce ascertainment bias
may find a paradoxical increase in disease if relying solely on historical comparisons. Our find-
ing of high pneumococcal incidence in age groups that mirror HIV prevalence together with
local hot spots also have implications for the post-vaccine era, since population reservoirs of
pneumococcal carriage and transmission in adults and other age groups ineligible for vaccina-
tion may persist following vaccine introduction in infants. Malawi introduced the pneumococ-
cal conjugate vaccine to the child population in November 2011. Surveillance is continuing to
observe possible reductions in incidence of adult disease and studies examining indirect effec-
tiveness of vaccination on older children and adults are also under way. Surveillance in the post
vaccine era will have to take into account heterogeneity in disease and ascertainment if accurate
estimates of vaccine direct and indirect effectiveness are to be made.
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